Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAFV600E inhibitors
- 1 January 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (1) , 46-54
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20130554)
- Major Projects on Control and Rectification of Water Body Pollution (2011ZX07204-001-2214 004)
- National Nature Science Foundation of China (31260004)
This publication has 31 references indexed in Scilit:
- Synthesis, biological evaluation and molecular docking of novel 5-phenyl-1H-pyrazol derivatives as potential BRAFV600E inhibitorsOrganic & Biomolecular Chemistry, 2013
- New insights in thyroid follicular cell biology and its impact in thyroid cancer therapyEndocrine-Related Cancer, 2007
- Melanoma biology and new targeted therapyNature, 2007
- Demonstration of a Genetic Therapeutic Index for Tumors Expressing Oncogenic BRAF by the Kinase Inhibitor SB-590885Cancer Research, 2006
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- Guilty as chargedCancer Cell, 2004
- BRAF as a potential therapeutic target in melanoma and other malignanciesCancer Cell, 2003
- Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinomaGut, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- The Raf/MEK/ERK pathway: new concepts of activationBiology of the Cell, 2001